June 2020 FDA Recall Drug by Medichem S.a.
D-1534-2020 - Microbial contamination of Non-Sterile Product; detection of the gram-negative bacillus Serratia marcescens in certain API batches

This Class I drug recall was voluntarily initiated by Medichem S.a. on June 24, 2020 for the product Drug. The FDA reported the reason for recall as microbial contamination of non-sterile product; detection of the gram-negative bacillus serratia marcescens in certain api batches. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-1534-2020

Reason for Recall
Microbial contamination of Non-Sterile Product; detection of the gram-negative bacillus Serratia marcescens in certain API batches
Initiated
06-24-2020
Reported
09-02-2020
Quantity
117,800 kg

Recall Profile & Regulatory Data

Class I - is a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death.
Chlorhexidine Gluconate 0012 For Manufacturing, Processing or Repacking, RX Only, Medichem, S.A. Poligono Industrial Celra, 17460, Celra, Girona (Spain/Espana); Fructuos Gelabert, 6-8, 08970, Sant Joan Despi, Barcelona (Spain/Espana) NDC 53296-0012-0

Batch or Lot Expiration Information

Lot# A-190571, exp. 11/29/21, A-190418, exp. 09/04/21, A-190503, exp. 10/25/21, A-190576, exp. 12/02/21, A-190537, exp. 11/15/21, A-200082, exp. 02/24/22, A-200085, exp. 02/25/22, A-200097, exp. 03/05/22, A-200116, exp. 03/13/22, A-200127, exp. 03/19/22, A-200131, exp. 03/20/22